跳至主要内容
临床试验/NCT05835154
NCT05835154
招募中
不适用

Improving Advance Care Planning Around Mobility Needs Among Patients With Sarcoma

Fred Hutchinson Cancer Center1 个研究点 分布在 1 个国家目标入组 20 人2025年7月8日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Metastatic Sarcoma
发起方
Fred Hutchinson Cancer Center
入组人数
20
试验地点
1
主要终点
Feasibility, as measured by the number of subjects accrued to the study
状态
招募中
最后更新
3个月前

概览

简要总结

This trial tests how well the advanced care planning around mobility needs checklist tool works to assess future mobility needs in patients with sarcoma. Gathering information about sarcoma patients that have had surgery to either save or remove a limb may help doctors learn more about a patient's mobility needs. Using an advance care planning mobility needs assessment may help improve the quality of life in patients with sarcoma by helping them plan for their future mobility needs.

详细描述

OUTLINE: FIELD TEST: Participants complete the advance care planning (ACP) Mobility Checklist on study. Participants complete questionnaires at baseline and after completing the checklist intervention and undergo interview on study. Participants' medical records are also reviewed.

注册库
clinicaltrials.gov
开始日期
2025年7月8日
结束日期
2026年3月31日
最后更新
3个月前
研究类型
Interventional
研究设计
Single Group
性别
All

研究者

责任方
Sponsor

入排标准

入选标准

  • PATIENTS: Age 18 years of age or older.
  • PATIENTS: English speaking
  • PATIENTS: Able to provide informed consent
  • PATIENTS: Have access to a computer or other device to fill out the online checklist
  • PATIENTS: Have had either limb salvage or amputation surgery for sarcoma within the last 6 months OR have metastatic (stage IV) sarcoma and are in active treatment.
  • CAREGIVERS: Age 18 years of age or older
  • CAREGIVERS: English speaking
  • CAREGIVERS: Able to provide informed consent
  • CAREGIVERS: Have access to a computer or other device to fill out the online checklist
  • CAREGIVERS: The person (family member or friend) whom the patient indicates being an informal caregiver

排除标准

  • 未提供

结局指标

主要结局

Feasibility, as measured by the number of subjects accrued to the study

时间窗: At enrollment

The number of participants accrued during the recruitment period.

Feasibility, as measured by the number of subjects to complete the intervention

时间窗: Through study completion, up to 4 weeks

The number of participants to complete the intervention.

Acceptability of the intervention: Acceptability E-Scale

时间窗: After completion of intervention (+ 1 week)

The Acceptability E-Scale is a 6-item scale, scored on a 5-point Likert scale (e.g., 1=very difficult; 5= very easy), with previously demonstrated good internal consistency (Cronbach's alpha=.76), with higher values indicating higher levels of acceptability.

Usability: System Usability Scale (SUS)

时间窗: After completion of intervention (+ 1 week)

Usability of the ACP Mobility Checklist will be assessed among patients using the System Usability Scale (SUS). The SUS is a 10-item scale, scored on a 5-point Likert scale (1=strongly disagree; 5=strongly agree), with higher values indicating higher levels of usability.

Acceptability: Satisfaction with the intervention

时间窗: After completion of intervention (+ 1 week)

Satisfaction with the intervention will be assessed with a single, 10-point Likert scale item assessing how satisfied participants are with the intervention (1= not at all satisfied, 10 = extremely satisfied). Higher values indicate higher ratings of satisfaction.

次要结局

  • Change in planning for mobility needs(From baseline to after completion of intervention (+ 1 week))
  • Change in functional status(From baseline to after completion of intervention (+ 1 week))
  • Change in discussion of advance directives(From baseline to after completion of intervention (+ 1 week))
  • Change in completion of advance directives(From baseline to after completion of intervention (+ 1 week))
  • Change in patients' engagement in clinical conversations (present/absent) with specialist providers(From baseline to after completion of intervention (+ 1 week))

研究点 (1)

Loading locations...

相似试验